Kathleen Welsh-Bohmer - Publications

Affiliations: 
Psychiatry & Behavioral Sciences Duke Medical School, Durham, NC, United States 

86 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Zhou X, Zou H, Lutz MW, Arbeev K, Akushevich I, Yashin A, Welsh-Bohmer KA, Luo S. Assessing tilavonemab efficacy in early Alzheimer's disease via longitudinal item response theory modeling. Alzheimer's & Dementia (New York, N. Y.). 10: e12471. PMID 38835820 DOI: 10.1002/trc2.12471  0.312
2024 Reese M, Wong MK, Cheong V, Ha CI, Cooter Wright M, Browndyke J, Moretti E, Devinney MJ, Habib AS, Moul JW, Shaw LM, Waligorska T, Whitson HE, Cohen HJ, Welsh-Bohmer KA, et al. Cognitive and cerebrospinal fluid Alzheimer's disease-related biomarker trajectories in older surgical patients and matched nonsurgical controls. Anesthesiology. PMID 38324729 DOI: 10.1097/ALN.0000000000004924  0.796
2023 Watts A, Haneline S, Welsh-Bohmer KA, Wu J, Alexander R, Swerdlow RH, Burns DK, Saunders AM. TOMM40 '523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOEɛ3 Homozygotes. Journal of Alzheimer's Disease : Jad. PMID 37718796 DOI: 10.3233/JAD-230066  0.371
2022 Grazia A, Altomare D, Preis L, Monsch AU, Cappa SF, Gauthier S, Frölich L, Winblad B, Welsh-Bohmer KA, Teipel SJ, Boccardi M. Feasibility of a standard cognitive assessment in European academic memory clinics. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36453876 DOI: 10.1002/alz.12830  0.307
2022 Atkins AS, Kraus MS, Welch M, Yuan Z, Stevens H, Welsh-Bohmer KA, Keefe RSE. Remote self-administration of digital cognitive tests using the Brief Assessment of Cognition: Feasibility, reliability, and sensitivity to subjective cognitive decline. Frontiers in Psychiatry. 13: 910896. PMID 36090378 DOI: 10.3389/fpsyt.2022.910896  0.679
2021 Kimmel HJ, Levine DA, Whitney RT, Forman J, Plassman BL, Fagerlin A, Welsh-Bohmer KA, Reale BK, Galecki AT, Blair E, Langa KM, Giordani B, Kollman C, Wang J, Zahuranec DB. A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks. Journal of Alzheimer's Disease : Jad. PMID 34924384 DOI: 10.3233/JAD-215155  0.345
2021 Shadyab AH, LaCroix AZ, Feldman HH, van Dyck CH, Okonkwo OC, Tam SP, Fairchild JK, Welsh-Bohmer KA, Matthews G, Bennett D, Shadyab AA, Schafer KA, Morrison RH, Kipperman SA, Mason J, et al. Recruitment of a multi-site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34297895 DOI: 10.1002/alz.12401  0.331
2021 Burns DK, Alexander RC, Welsh-Bohmer KA, Culp M, Chiang C, O'Neil J, Evans RM, Harrigan P, Plassman BL, Burke JR, Wu J, Lutz MW, Haneline S, Schwarz AJ, Schneider LS, et al. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 20: 537-547. PMID 34146512 DOI: 10.1016/S1474-4422(21)00043-0  0.369
2021 Levine DA, Galecki AT, Plassman BL, Fagerlin A, Wallner LP, Langa KM, Whitney RT, Nallamothu BK, Morgenstern LB, Reale BK, Blair EM, Giordani B, Welsh-Bohmer KA, Kabeto MU, Zahuranec DB. The Association Between Mild Cognitive Impairment Diagnosis and Patient Treatment Preferences: a Survey of Older Adults. Journal of General Internal Medicine. PMID 33963503 DOI: 10.1007/s11606-021-06839-w  0.311
2020 Smith PJ, Mabe SM, Sherwood A, Murali Doraiswamy P, Welsh-Bohmer KA, Burke JR, Kraus WE, Lin PH, Browndyke JN, Babyak MA, Hinderliter AL, Blumenthal JA. Metabolic and Neurocognitive Changes Following Lifestyle Modification: Examination of Biomarkers from the ENLIGHTEN Randomized Clinical Trial. Journal of Alzheimer's Disease : Jad. PMID 32925039 DOI: 10.3233/Jad-200374  0.699
2019 Blumenthal JA, Smith PJ, Mabe S, Hinderliter A, Welsh-Bohmer K, Browndyke JN, Doraiswamy PM, Lin PH, Kraus WE, Burke JR, Sherwood A. Longer Term Effects of Diet and Exercise on Neurocognition: 1-Year Follow-up of the ENLIGHTEN Trial. Journal of the American Geriatrics Society. PMID 31755550 DOI: 10.1111/Jgs.16252  0.738
2019 Klinger RY, Cooter M, Bisanar T, Terrando N, Berger M, Podgoreanu MV, Stafford-Smith M, Newman MF, Mathew JP, Blumenthal JA, Karhausen JA, Kertai MD, Krishnamoorthy V, Li YJ, Swaminathan M, ... ... Welsh-Bohmer KA, et al. Intravenous Lidocaine Does Not Improve Neurologic Outcomes after Cardiac Surgery: A Randomized Controlled Trial. Anesthesiology. PMID 30870159 DOI: 10.1097/Aln.0000000000002668  0.771
2019 Tsui-Caldwell YHW, Farrer TJ, McDonnell Z, Christensen Z, Finuf C, Bigler ED, Tschanz JT, Norton MC, Welsh-Bohmer KA. MRI Clinical Ratings and Cognitive Function in a Cross-Sectional Population Study of Dementia: The Cache County Memory Study. The Journal of Prevention of Alzheimer's Disease. 6: 100-107. PMID 30756116 DOI: 10.14283/jpad.2019.1  0.319
2019 Welsh-Bohmer KA, Atkins AS, Plassman BL, Khan A, Chiang C, Culp M, O'Neil J, Walter R, Haneline S, Arbuckle J, Brewster S, Maruyama Y, Swanson T, Hayden KM, Romero H, et al. O4-11-02: DEFINING COGNITION IN PRE-DEMENTIA CLINICAL TRIALS: BASELINE NEUROPSYCHOLOGICAL DATA FROM THE TOMMORROW STUDY Alzheimer's & Dementia. 15: P1262-P1262. DOI: 10.1016/J.Jalz.2019.06.4801  0.776
2018 Blumenthal JA, Smith PJ, Mabe S, Hinderliter A, Lin PH, Liao L, Welsh-Bohmer KA, Browndyke JN, Kraus WE, Doraiswamy PM, Burke JR, Sherwood A. Lifestyle and neurocognition in older adults with cognitive impairments: A randomized trial. Neurology. PMID 30568005 DOI: 10.1212/Wnl.0000000000006784  0.77
2018 Morrison RL, Pei H, Novak G, Kaufer DI, Welsh-Bohmer KA, Ruhmel S, Narayan VA. A computerized, self-administered test of verbal episodic memory in elderly patients with mild cognitive impairment and healthy participants: A randomized, crossover, validation study. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 647-656. PMID 30456291 DOI: 10.1016/j.dadm.2018.08.010  0.345
2018 Romero HR, Monsch AU, Hayden KM, Plassman BL, Atkins AS, Keefe RSE, Brewster S, Chiang C, O'Neil J, Runyan G, Atkinson MJ, Crawford S, Budur K, Burns DK, Welsh-Bohmer KA. TOMMORROW neuropsychological battery: German language validation and normative study. Alzheimer's & Dementia (New York, N. Y.). 4: 314-323. PMID 30094331 DOI: 10.1016/J.Trci.2018.06.009  0.782
2018 Weintraub S, Carrillo MC, Farias ST, Goldberg TE, Hendrix JA, Jaeger J, Knopman DS, Langbaum JB, Park DC, Ropacki MT, Sikkes SAM, Welsh-Bohmer KA, Bain LJ, Brashear R, Budur K, et al. Measuring cognition and function in the preclinical stage of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 4: 64-75. PMID 29955653 DOI: 10.1016/J.Trci.2018.01.003  0.308
2018 Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JP, Weiner MW, Aisen P, Weiner M, Aisen P, ... ... Welsh-Bohmer KA, et al. 18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. Anesthesiology. PMID 29389750 DOI: 10.1097/Aln.0000000000002103  0.76
2017 Weintraub S, Besser L, Dodge HH, Teylan M, Ferris S, Goldstein FC, Giordani B, Kramer J, Loewenstein D, Marson D, Mungas D, Salmon D, Welsh-Bohmer K, Zhou XH, Shirk SD, et al. Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Disease and Associated Disorders. PMID 29240561 DOI: 10.1097/Wad.0000000000000223  0.354
2017 Browndyke JN, Berger M, Smith PJ, Harshbarger TB, Monge ZA, Panchal V, Bisanar TL, Glower DD, Alexander JH, Cabeza R, Welsh-Bohmer K, Newman MF, Mathew JP. Task-related changes in degree centrality and local coherence of the posterior cingulate cortex after major cardiac surgery in older adults. Human Brain Mapping. PMID 29164774 DOI: 10.1002/Hbm.23898  0.769
2017 Blumenthal JA, Smith PJ, Mabe S, Hinderliter A, Welsh-Bohmer K, Browndyke JN, Lin PH, Kraus W, Doraiswamy PM, Burke J, Sherwood A. Lifestyle and Neurocognition in Older Adults with Cardiovascular Risk Factors and Cognitive Impairment. Psychosomatic Medicine. PMID 28437380 DOI: 10.1097/Psy.0000000000000474  0.752
2017 Atkins AS, Khan A, Welsh-Bohmer KA, Plassman BL, Randolph C, Harrison J, Keefe RS. EXPANDING THE BRIEF ASSESSMENT OF COGNITION (BAC-APP) FOR ASSESSMENT OF COGNITION IN AGING: INITIAL FINDINGS FROM AN ONGOING NORMATIVE STUDY Alzheimer's & Dementia. 13: P1574-P1575. DOI: 10.1016/J.Jalz.2017.07.741  0.663
2016 Browndyke JN, Berger M, Harshbarger TB, Smith PJ, White W, Bisanar TL, Alexander JH, Gaca JG, Welsh-Bohmer K, Newman MF, Mathew JP. Resting-State Functional Connectivity and Cognition After Major Cardiac Surgery in Older Adults without Preoperative Cognitive Impairment: Preliminary Findings. Journal of the American Geriatrics Society. PMID 27858963 DOI: 10.1111/Jgs.14534  0.789
2016 Foster CM, Addis DR, Ford JH, Kaufer DI, Burke JR, Browndyke JN, Welsh-Bohmer KA, Giovanello KS. Prefrontal contributions to relational encoding in amnestic mild cognitive impairment. Neuroimage. Clinical. 11: 158-66. PMID 26937384 DOI: 10.1016/J.Nicl.2016.01.008  0.746
2016 Foster CM, Addis DR, Ford JH, Kaufer DI, Burke JR, Browndyke JN, Welsh-Bohmer KA, Giovanello KS. Prefrontal contributions to relational encoding in amnestic mild cognitive impairment Neuroimage: Clinical. 11: 158-166. DOI: 10.1016/j.nicl.2016.01.008  0.765
2015 Makeeva OA, Romero HR, Markova VV, Melikyan ZA, Zhukova IA, Minaycheva LI, Buikin SV, Zhukova NG, Maruyama Y, Plassman BL, Roses AD, Welsh-Bohmer K. P4-284: Vascular risk factors confer domain-specific deficits in cognitive performance within an elderly russian population Alzheimer's & Dementia. 11: P894-P895. DOI: 10.1016/J.Jalz.2015.08.114  0.69
2015 Budur K, Welsh-Bohmer K, Burns DK, Chiang C, O'Neil J, Runyan G, Culp M, Crenshaw DG, Lutz MW, Metz CA, Saunders AM, Yarbrough D, Yarnall D, Lai E, Brannan SK, et al. P2-083: Progress in the tommorrow study: A pharmacogenetics supported clinical trial to delay onset of mild cognitive impairment due to Alzheimer's disease with low-dose pioglitazone Alzheimer's & Dementia. 11: P515-P515. DOI: 10.1016/J.Jalz.2015.06.620  0.362
2014 Hayden KM, Makeeva OA, Newby LK, Plassman BL, Markova VV, Dunham A, Romero HR, Melikyan ZA, Germain CM, Welsh-Bohmer KA, Roses AD. A comparison of neuropsychological performance between US and Russia: preparing for a global clinical trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 760-768.e1. PMID 25066497 DOI: 10.1016/J.Jalz.2014.02.008  0.675
2014 Romero HR, Welsh-Bohmer KA, Gwyther LP, Edmonds HL, Plassman BL, Germain CM, McCart M, Hayden KM, Pieper C, Roses AD. Community engagement in diverse populations for Alzheimer disease prevention trials. Alzheimer Disease and Associated Disorders. 28: 269-74. PMID 24614272 DOI: 10.1097/Wad.0000000000000029  0.656
2014 Hayden KM, Kuchibhatla M, Romero HR, Plassman BL, Burke JR, Browndyke JN, Welsh-Bohmer KA. Pre-clinical cognitive phenotypes for Alzheimer disease: a latent profile approach. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 1364-74. PMID 24080384 DOI: 10.1016/J.Jagp.2013.07.008  0.797
2014 Budur K, Welsh-Bohmer K, Burns D, Chiang C, O'Neil J, Runyan G, Cyganowski M, Crenshaw DG, Lutz MW, Metz C, Saunders A, Yarbrough D, Yarnall D, Lai E, Brannan S, et al. P4-073: A PHARMACOGENETICS-SUPPORTED CLINICAL TRIAL TO DELAY ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE USING LOW-DOSE PIOGLITAZONE: AN UPDATE ON THE TOMORROW STUDY Alzheimer's & Dementia. 10: P809-P810. DOI: 10.1016/J.Jalz.2014.05.1588  0.364
2014 Espeland MA, Vaughan L, Romero H, Hayden KM, Plassman BL, Welsh-Bohmer KA. P3-398: DERIVING AN INFORMED NEUROCOGNITIVE COMPOSITE MEASURE FOR DELAY-OF-ONSET TRIALS IN MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE (MCI-AD) Alzheimer's & Dementia. 10: P776-P776. DOI: 10.1016/J.Jalz.2014.05.1492  0.716
2014 Atkins AS, Keefe RS, Vaughan AW, Turcotte NM, Makeeva OA, Monsch AU, Frisoni GB, Parapini M, Melikyan ZA, Brewster S, O'Neil J, Schuster J, Lymboura M, Romero H, Hayden KM, ... ... Welsh-Bohmer KA, et al. P3-255: CULTURAL ADAPTATION OF TRANSLATED NEUROCOGNITIVE ASSESSMENTS IN RUSSIA, SWITZERLAND AND ITALY: PILOT TESTING FOR A PROGRAM TO DELAY THE ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P725-P726. DOI: 10.1016/J.Jalz.2014.05.1347  0.78
2014 Welsh-Bohmer KA, Romero HR, Hayden KM, Plassman BL, Atkins AS, Vaughan AW, Turcotte N, Keefe RS, Makeeva O, Monsch AU, Frisoni GB, Melikyan Z, Brewster SR, Chiang C, O'Neil J, et al. P2-392: CROSS-CULTURAL VALIDATION AND NORMATIVE STUDY OF A NEUROPSYCHOLOGICAL BATTERY USED IN THE DETERMINATION OF CLINICAL ENDPOINTS TO DELAY ONSET OF MCI Alzheimer's & Dementia. 10: P622-P623. DOI: 10.1016/J.Jalz.2014.05.1072  0.639
2013 Brummett BH, Austin SB, Welsh-Bohmer KA, Williams RB, Siegler IC. Long-Term Impact of Caregiving and Metabolic Syndrome with Perceived Decline in Cognitive Function 8 Years Later: A Pilot Study Suggesting Important Avenues for Future Research. Open Journal of Medical Psychology. 2: 23-28. PMID 24634805 DOI: 10.4236/Ojmp.2013.21005  0.315
2013 Hendrix SB, Welsh-Bohmer KA. Separation of cognitive domains to improve prediction of progression from mild cognitive impairment to Alzheimer's disease. Alzheimer's Research & Therapy. 5: 22. PMID 23680123 DOI: 10.1186/alzrt176  0.376
2013 Tschanz JT, Pfister R, Wanzek J, Corcoran C, Smith K, Tschanz BT, Steffens DC, Østbye T, Welsh-Bohmer KA, Norton MC. Stressful life events and cognitive decline in late life: moderation by education and age. The Cache County Study. International Journal of Geriatric Psychiatry. 28: 821-30. PMID 23037866 DOI: 10.1002/Gps.3888  0.303
2013 Blumenthal JA, Smith PJ, Welsh-Bohmer K, Babyak MA, Browndyke J, Lin PH, Doraiswamy PM, Burke J, Kraus W, Hinderliter A, Sherwood A. Can lifestyle modification improve neurocognition? Rationale and design of the ENLIGHTEN clinical trial. Contemporary Clinical Trials. 34: 60-9. PMID 23000080 DOI: 10.1016/J.Cct.2012.09.004  0.731
2013 Browndyke JN, Giovanello K, Petrella J, Hayden K, Chiba-Falek O, Tucker KA, Burke JR, Welsh-Bohmer KA. Phenotypic regional functional imaging patterns during memory encoding in mild cognitive impairment and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 284-94. PMID 22841497 DOI: 10.1016/J.Jalz.2011.12.006  0.748
2013 Hayden K, Makeeva O, Dunham A, Markova V, Melikyan Z, Zhukova I, Zhukova N, Minaycheva L, Buikin S, Abushaeva M, Burlutskaya S, Karas E, Starinskaya E, Maruyama Y, Romero H, ... ... Welsh-Bohmer K, et al. P4-319: Construct validity of MoCA subscales across community-based registries, from North Carolina to Tomsk, Russia Alzheimer's & Dementia. 9: P849-P850. DOI: 10.1016/J.Jalz.2013.08.271  0.601
2013 Kurtzke M, Romero H, Welsh-Bohmer K. P2-301: Use of social media for recruitment in Alzheimer's disease research Alzheimer's & Dementia. 9: P470-P470. DOI: 10.1016/J.Jalz.2013.05.949  0.625
2013 Roses A, Welsh-Bohmer K, Burns D, Chiang C, Crenshaw DG, Lutz MW, Metz C, Saunders AM, Yarbrough D, Ogrinc F, Talbott S, Brannan S, Malholtra M. P4-065: A pharmacogenetics-supported clinical trial to delay onset of mild cognitive impairment due to Alzheimer's disease Alzheimer's & Dementia. 9: P727-P727. DOI: 10.1016/j.jalz.2013.05.1454  0.385
2013 Hayden K, Kuchibhatla M, Plassman B, Germain C, Romero H, Welsh-Bohmer K. O3-09-02: The use of reliable change indices to complement norms in the early identification of cognitive decline Alzheimer's & Dementia. 9: P535-P536. DOI: 10.1016/J.Jalz.2013.04.286  0.679
2013 Welsh-Bohmer K, Romero H, Hayden K, Plassman B, Germain C, Sano M, Espeland M, Craft S, Monsch A, Schneider L, Chiang C, Haneline S, Oneil J, Malholtra M, Brannan S, et al. O1-06-01: Challenges in international clinical trials to delay early symptomatic Alzheimer's disease Alzheimer's & Dementia. 9: P137-P138. DOI: 10.1016/J.Jalz.2013.04.079  0.642
2012 Wee CY, Yap PT, Denny K, Browndyke JN, Potter GG, Welsh-Bohmer KA, Wang L, Shen D. Resting-state multi-spectrum functional connectivity networks for identification of MCI patients. Plos One. 7: e37828. PMID 22666397 DOI: 10.1371/Journal.Pone.0037828  0.691
2012 Giovanello KS, De Brigard F, Hennessey Ford J, Kaufer DI, Burke JR, Browndyke JN, Welsh-Bohmer KA. Event-related functional magnetic resonance imaging changes during relational retrieval in normal aging and amnestic mild cognitive impairment. Journal of the International Neuropsychological Society : Jins. 18: 886-97. PMID 22622022 DOI: 10.1017/S1355617712000689  0.755
2012 Wee CY, Yap PT, Zhang D, Denny K, Browndyke JN, Potter GG, Welsh-Bohmer KA, Wang L, Shen D. Identification of MCI individuals using structural and functional connectivity networks. Neuroimage. 59: 2045-56. PMID 22019883 DOI: 10.1016/J.Neuroimage.2011.10.015  0.728
2012 Makeeva O, Markova V, Zhukova I, Melikyan Z, Minaycheva L, Buikin S, Osinova E, Abushaeva M, Botkina O, Musina N, Starinskaya E, Zhukova N, Maruyama Y, McCart M, MacDonald H, ... ... Welsh-Bohmer K, et al. P4-327: Montreal Cognitive Assessment (MoCA) population-based study of Russian elderly Alzheimer's & Dementia. 8: S773-S773. DOI: 10.1016/J.Jalz.2013.08.108  0.693
2012 Roses AD, Welsh-Bohmer K, Burns D, Chiang C, Crenshaw DG, Lutz MW, Metz C, Saunders AM, Talbott S, Yarbrough D, Brannan S. P4-269: A pharmacogenetic-supported clinical trial to delay onset of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) Alzheimer's & Dementia. 8: S753-S753. DOI: 10.1016/J.Jalz.2013.08.050  0.381
2012 Luck T, Warren L, Welsh-Bohmer K, Riedel-Heller S, Maier W, Breitner J. P4-265: Disordered ‘instrumental’ abilities and impaired IADL as potent predictors of imminent dementia in persons with cognitive impairment Alzheimer's & Dementia. 8: S751-S752. DOI: 10.1016/J.Jalz.2013.08.046  0.336
2012 Hayden K, Romero H, Plassman B, Burke JR, Welsh-Bohmer K. P2-285: Construct validity of MoCA subscales in a population-based sample Alzheimer's & Dementia. 8: P362-P363. DOI: 10.1016/J.Jalz.2012.05.993  0.603
2012 Romero H, Hayden K, Plassman B, Welsh-Bohmer K, Burke JR. P3-239: Vascular risk and cognition in the Alzheimer's Disease Prevention Registry Alzheimer's & Dementia. 8: P544-P544. DOI: 10.1016/J.Jalz.2012.05.1461  0.709
2011 Hayden KM, Jones RN, Zimmer C, Plassman BL, Browndyke JN, Pieper C, Warren LH, Welsh-Bohmer KA. Factor structure of the National Alzheimer's Coordinating Centers uniform dataset neuropsychological battery: an evaluation of invariance between and within groups over time. Alzheimer Disease and Associated Disorders. 25: 128-37. PMID 21606904 DOI: 10.1097/Wad.0B013E3181Ffa76D  0.771
2011 Tschanz JT, Corcoran CD, Schwartz S, Treiber K, Green RC, Norton MC, Mielke MM, Piercy K, Steinberg M, Rabins PV, Leoutsakos JM, Welsh-Bohmer KA, Breitner JC, Lyketsos CG. Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 19: 532-42. PMID 21606896 DOI: 10.1097/Jgp.0B013E3181Faec23  0.315
2011 Treiber KA, Carlson MC, Corcoran C, Norton MC, Breitner JC, Piercy KW, Deberard MS, Stein D, Foley B, Welsh-Bohmer KA, Frye A, Lyketsos CG, Tschanz JT. Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression study. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 66: 416-25. PMID 21441386 DOI: 10.1093/Geronb/Gbr023  0.389
2011 Plassman BL, Langa KM, McCammon RJ, Fisher GG, Potter GG, Burke JR, Steffens DC, Foster NL, Giordani B, Unverzagt FW, Welsh-Bohmer KA, Heeringa SG, Weir DR, Wallace RB. Incidence of dementia and cognitive impairment, not dementia in the United States. Annals of Neurology. 70: 418-26. PMID 21425187 DOI: 10.1002/Ana.22362  0.335
2011 Wee CY, Yap PT, Li W, Denny K, Browndyke JN, Potter GG, Welsh-Bohmer KA, Wang L, Shen D. Enriched white matter connectivity networks for accurate identification of MCI patients. Neuroimage. 54: 1812-22. PMID 20970508 DOI: 10.1016/J.Neuroimage.2010.10.026  0.71
2011 Lee H, Norton M, Corcoran C, Tschanz J, Ostbye T, Smith K, Breitner J, Welsh-Bohmer K. P2-152: Late-life widowhood is associated with faster cognitive decline: The Cache County Study. Alzheimer's & Dementia. 7: S360-S360. DOI: 10.1016/J.Jalz.2011.05.1038  0.309
2010 Smith PJ, Blumenthal JA, Babyak MA, Craighead L, Welsh-Bohmer KA, Browndyke JN, Strauman TA, Sherwood A. Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension. 55: 1331-8. PMID 20305128 DOI: 10.1161/Hypertensionaha.109.146795  0.696
2010 Smith PJ, Blumenthal JA, Hoffman BM, Cooper H, Strauman TA, Welsh-Bohmer K, Browndyke JN, Sherwood A. Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosomatic Medicine. 72: 239-52. PMID 20223924 DOI: 10.1097/Psy.0B013E3181D14633  0.693
2010 Dennis NA, Browndyke JN, Stokes J, Need A, Burke JR, Welsh-Bohmer KA, Cabeza R. Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 303-11. PMID 19744893 DOI: 10.1016/J.Jalz.2009.07.003  0.703
2010 Welsh-Bohmer KA, Plassman BL, Hayden KM. Genetic and environmental contributions to cognitive decline in aging and Alzheimer's disease Annual Review of Gerontology and Geriatrics. 30: 81-114. DOI: 10.1891/0198-8794.30.81  0.317
2010 Romero HR, Hayden KM, Pieper CF, Sanders L, Welsh-Bohmer KA. P2-144: Improving detection of prodromal Alzheimer's disease in diverse populations Alzheimer's & Dementia. 6: S355-S356. DOI: 10.1016/J.Jalz.2010.05.1191  0.639
2010 Romero HR, Hayes SM, Welsh-bohmer KA. Cognitive Domains Affected by Conditions of Ageing and the Role of Neuropsychological Testing Principles and Practice of Geriatric Psychiatry: Third Edition. 389-396. DOI: 10.1002/9780470669600.ch62  0.735
2010 Hayden KM, Breitner JCS, Welsh-Bohmer KA. Apolipoprotein E ε4 status and cognitive decline with and without dementia - Reply Archives of Neurology. 67: 1036-1037. DOI: 10.1001/Archneurol.2010.164  0.322
2009 Hayden KM, Zandi PP, West NA, Tschanz JT, Norton MC, Corcoran C, Breitner JC, Welsh-Bohmer KA. Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study. Archives of Neurology. 66: 1378-83. PMID 19901170 DOI: 10.1001/Archneurol.2009.237  0.316
2009 Linnertz C, Saucier L, Ge D, Cronin KD, Burke JR, Browndyke JN, Hulette CM, Welsh-Bohmer KA, Chiba-Falek O. Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues. Plos One. 4: e7480. PMID 19834617 DOI: 10.1371/Journal.Pone.0007480  0.674
2009 Hayden KM, Warren LH, Plassman B, Browndyke J, Pieper C, Sanders L, Welsh-Bohmer KA. P4-057: Neuropsychological domains in mild cognitive impairment and normal aging: Results from the NACC UDS study Alzheimer's & Dementia. 5: P448-P448. DOI: 10.1016/J.Jalz.2009.04.826  0.753
2009 Munger RG, Charoonruk J, Tschanz J, Zandi P, Corcoran C, Wengreen H, Hayden K, Norton M, Welsh-Bohmer K. P3-154: Prospective study of diabetes and cognitive decline and dementia subtypes in Cache County, Utah, USA Alzheimer's & Dementia. 5: P389-P389. DOI: 10.1016/J.Jalz.2009.04.1028  0.302
2008 Browndyke JN, Paskavitz J, Sweet LH, Cohen RA, Tucker KA, Welsh-Bohmer KA, Burke JR, Schmechel DE. Neuroanatomical correlates of malingered memory impairment: event-related fMRI of deception on a recognition memory task. Brain Injury. 22: 481-9. PMID 18465389 DOI: 10.1080/02699050802084894  0.735
2008 Browndyke JN, Burke JR, Dennis NA, Cabeza R, Welsh-Bohmer K. P4-358: Acetylcholinesterase inhibitor dose-response effects on the neural correlates of semantic memory: Preliminary pharmacological fMRI data Alzheimer's & Dementia. 4: T778-T778. DOI: 10.1016/J.Jalz.2008.05.2429  0.689
2008 Browndyke JN, Dennis NA, Stokes J, Welsh-Bohmer KA, Burke JR, Goldstein DB, Cabeza R. IC-P3-173: Genetic risk for Alzheimer's disease influences brain activity in young adults Alzheimer's & Dementia. 4: T76-T77. DOI: 10.1016/J.Jalz.2008.05.117  0.703
2007 Hayden KM, Zandi PP, Khachaturian AS, Szekely CA, Fotuhi M, Norton MC, Tschanz JT, Pieper CF, Corcoran C, Lyketsos CG, Breitner JC, Welsh-Bohmer KA. Does NSAID use modify cognitive trajectories in the elderly? The Cache County study. Neurology. 69: 275-82. PMID 17636065 DOI: 10.1212/01.Wnl.0000265223.25679.2A  0.306
2006 Welsh-Bohmer KA, Breitner JC, Hayden KM, Lyketsos C, Zandi PP, Tschanz JT, Norton MC, Munger R. Modifying dementia risk and trajectories of cognitive decline in aging: the Cache County Memory Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 257-60. PMID 19595895 DOI: 10.1016/J.Jalz.2006.04.011  0.389
2006 Plassman BL, Steffens DC, Burke JR, Welsh-Bohmer KA, Newman TN, Drosdick D, Helms MJ, Potter GG, Breitner JC. Duke Twins Study of Memory in Aging in the NAS-NRC Twin Registry. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 9: 950-7. PMID 17254435 DOI: 10.1375/183242706779462381  0.362
2006 Tschanz JT, Welsh-Bohmer KA, Lyketsos CG, Corcoran C, Green RC, Hayden K, Norton MC, Zandi PP, Toone L, West NA, Breitner JC. Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurology. 67: 229-34. PMID 16864813 DOI: 10.1212/01.Wnl.0000224748.48011.84  0.348
2006 Sheline YI, Barch DM, Garcia K, Gersing K, Pieper C, Welsh-Bohmer K, Steffens DC, Doraiswamy PM. Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biological Psychiatry. 60: 58-65. PMID 16414031 DOI: 10.1016/j.biopsych.2005.09.019  0.32
2005 Hayden KM, Warren LH, Pieper CF, Østbye T, Tschanz JT, Norton MC, Breitner JC, Welsh-Bohmer KA. Identification of VaD and AD prodromes: the Cache County Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 1: 19-29. PMID 19595812 DOI: 10.1016/J.Jalz.2005.06.002  0.376
2005 Lyketsos CG, Toone L, Tschanz J, Rabins PV, Steinberg M, Onyike CU, Corcoran C, Norton M, Zandi P, Breitner JC, Welsh-Bohmer K, Anthony J, Østbye T, Bigler E, Pieper C, et al. Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 13: 656-64. PMID 16085781 DOI: 10.1097/00019442-200508000-00004  0.352
2005 Lyketsos CG, Toone L, Tschanz J, Rabins PV, Steinberg M, Onyike CU, Corcoran C, Norton M, Zandi P, Breitner JCS, Welsh-Bohmer K. Population-based study of medical comorbidity in early dementia and "Cognitive Impairment, No Dementia (CIND)". Association with functional and cognitive impairment: The Cache County Study American Journal of Geriatric Psychiatry. 13: 656-664. DOI: 10.1097/00019442-200508000-00004  0.365
2002 Bigler ED, Tate DF, Miller MJ, Rice SA, Hessel CD, Earl HD, Tschanz JT, Plassman B, Welsh-Bohmer KA. Dementia, asymmetry of temporal lobe structures, and apolipoprotein E genotype: relationships to cerebral atrophy and neuropsychological impairment. Journal of the International Neuropsychological Society : Jins. 8: 925-33. PMID 12405544 DOI: 10.1017/S1355617702870072  0.3
2000 Welsh-Bohmer KA. Neuropsychologoical predictors of cognitive decline Neurobiology of Aging. 21: 3. DOI: 10.1016/S0197-4580(00)82688-3  0.347
1998 Hulette CM, Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, McIntyre LM. Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. Journal of Neuropathology and Experimental Neurology. 57: 1168-74. PMID 9862640 DOI: 10.1097/00005072-199812000-00009  0.348
1997 Plassman BL, Welsh-Bohmer KA, Bigler ED, Johnson SC, Anderson CV, Helms MJ, Saunders AM, Breitner JC. Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology. 48: 985-9. PMID 9109888 DOI: 10.1212/Wnl.48.4.985  0.315
1997 Hulette C, Murray M, Mash D, Welsh-Bohmer K. NEUROPATHOLOGICAL AND NEUROPSYCHOLOGICAL CORRELATES OF PRECUNICAL ALZHEIMERʼS DISEASE IN COGNITIVELY NORMAL INDIVIDUALS Journal of Neuropathology and Experimental Neurology. 56: 578. DOI: 10.1097/00005072-199705000-00041  0.347
Show low-probability matches.